Get access

Surgical management of Dupuytren's contracture in Europe: regional analysis of a surgeon survey and patient chart review


  • Disclosure

    Drs Bainbridge, Dahlin, Dias and Leclercq have received support/funding from Pfizer Inc. J. C. Cappelleri and R. A. Gerber are employees and stockholders of Pfizer Inc.; P. P. Szczypa is an employee and stockholder of Pfizer Ltd. D. Guerin is an employee at A+A Healthcare Marketing Research, who was a paid consultant to Pfizer Inc. for this study.

Correspondence to:

Joseph Dias, Department of Health Sciences, Clinical Division of Orthopaedic Surgery, Clinical Sciences Unit, Off Ward 11, Leicester General Hospital, Gwendolen Road, Leicester LE5 4PW, UK

Tel.: 00 44 116-258-4702

Fax: + 44 116 258 4617




We explored regional variations in the surgical management of patients with Dupuytren's contracture (DC) in 12 European countries using a surgeon survey and patient chart review.


Twelve countries participated: Denmark, Finland, Sweden (Nordic region); Czech Republic, Hungary, Poland (East); France, Germany, the Netherlands, UK (West); Italy, Spain (Mediterranean). For the survey, a random sample of orthopaedic/plastic surgeons (= 687) with 3–30 years’ experience was asked about DC procedures performed during the previous 12 months. For the chart review (= 3357), information from up to five consecutive patients was extracted. Descriptive statistics are reported.


Ninety-five per cent of all surgeons used fasciectomy for DC, followed by fasciotomy (70%), dermofasciectomy (38%) and percutaneous needle fasciotomy (35%). Most surgeons were satisfied with fasciectomy over other procedures. Recommended time away from work and duration of physical therapy increased with the invasiveness of the procedure. The intra-operative complication rate was 4.0%; the postoperative complication rate was 34%. Overall, ≥ 97% of the procedures were rated by surgeons as having a positive outcome. Across all regions, 54% of patients had no nodules or contracture after the procedures. Only 2% of patients required retreatment within the first year of surgery. Important inter- and intraregional differences in these aspects of patient management are described.


Understanding current regional treatment patterns and their relationships to country-specific health systems may facilitate earlier identification of, and intervention for, DD and help to optimise the overall treatment for patients with this chronic condition.

Get access to the full text of this article